MFDS
- Status: likely_approved
🇰🇷 Alomide in South Korea
Alomide (LODOXAMIDE) regulatory status in South Korea.
Marketing authorisation
Alomide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Alomide approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Alomide in South Korea?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.